Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.

Source:http://linkedlifedata.com/resource/pubmed/id/3600915

Download in:

View as

General Info

PMID
3600915